You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 9 No. 3, May-Jun 2007 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Biomaterials and Implants
 •Alert me on articles by topic

Injectable Tissue-Engineered Cartilage Using a Fibrin Sealant

Jinsoon Chang, MD, PhD; Jk J. Rasamny, BA; Stephen S. Park, MD

Arch Facial Plast Surg. 2007;9(3):161-166.

Objective  To investigate a commercially available fibrin sealant as a vehicle for developing injectable tissue-engineered cartilage.

Methods  Fibrin glue was mixed with autogenous chondrocytes from rabbits (n = 15). This isolate was injected along their nasal dorsa using 1 of 3 different fibrin glue concentrations. The samples were harvested at 8 weeks and compared with elastin and hyaline cartilage controls.

Results  Neocartilage was created along a linear injection tract on the dorsa of the nasal bones in 5 of 15 rabbits. Higher thrombin concentrations proved to be directly correlated with successful creation of injectable cartilage. Histologically, the staining patterns of both hematoxylin-eosin and safranin O stains were identical to that of normal auricular control cartilage. The presence of elastin fibers was observed following Verhoeff staining. No foreign body reaction was observed from the host.

Conclusions  This study demonstrated a successful method for percutaneous injection of tissue-engineered cartilage as a mixture of chondrocytes suspended in fibrin glue. The thrombin concentration, along with the concentration of fibrinogen and chondrocytes, must be optimized to succeed consistently in cartilage growth.


Author Affiliations: Department of Otolaryngology, Inje University, Seoul Paik Hospital, Seoul, South Korea (Dr Chang); School of Medicine, University of Virginia, Charlottesville (Mr Rasamny); and Department of Otolaryngology–Head and Neck Surgery, University of Virginia Health System, Charlottesville (Dr Park).







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.